Theravance Biopharma, Inc. (TBPH)

Theravance Biopharma Revenue

Theravance Biopharma had revenue of $17.70M in the quarter ending March 31, 2026, with 15.02% growth. This brings the company's revenue in the last twelve months to $109.78M, up 68.20% year-over-year. In the year 2025, Theravance Biopharma had annual revenue of $107.46M with 66.92% growth.

• Revenue (ttm): $109.78M
• Revenue Growth: +68.20%
• P/S Ratio: 7.81
• Revenue / Employee: $1,219,722
• Employees: 90
• Market Cap: 857.84M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	107.46M	43.08M	66.92%
Dec 31, 2024	64.38M	6.96M	12.12%
Dec 31, 2023	57.42M	6.08M	11.84%
Dec 31, 2022	51.35M	-3.97M	-7.17%
Dec 31, 2021	55.31M	-16.55M	-23.03%
Dec 31, 2020	71.86M	-1.56M	-2.12%
Dec 31, 2019	73.41M	13.04M	21.61%
Dec 31, 2018	60.37M	44.98M	292.37%
Dec 31, 2017	15.39M	-33.26M	-68.37%
Dec 31, 2016	48.65M	6.52M	15.48%
Dec 31, 2015	42.13M	30.44M	260.42%
Dec 31, 2014	11.69M	11.46M	5,071.68%
Dec 31, 2013	226.00K	-129.92M	-99.83%
Dec 31, 2012	130.15M	-	-
Dec 31, 2011	-	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error